Skip to main content

ADVERTISEMENT

Jolynn Tumolo

News
04/05/2023
Jolynn Tumolo
A Class II recall has been issued for simvastatin tablets due to deviations from due to deviations from Current Good Manufacturing Practices.
A Class II recall has been issued for simvastatin tablets due to deviations from due to deviations from Current Good Manufacturing Practices.
A Class II recall has been...
04/05/2023
Pharmacy Learning Network
News
04/05/2023
Jolynn Tumolo
New research suggests people with hemophilia had a consistently higher prevalence of hemorrhagic stroke, intracranial hemorrhage, and gastrointestinal bleeding compared to those without the disorder.
New research suggests people with hemophilia had a consistently higher prevalence of hemorrhagic stroke, intracranial hemorrhage, and gastrointestinal bleeding compared to those without the disorder.
New research suggests people...
04/05/2023
First Report Managed Care
News
04/04/2023
Jolynn Tumolo
“The high comorbidity burden highlighted in this study, in terms of number and severity of type 2 inflammatory conditions, suggests the importance of identifying patients with type 2 inflammation,” researchers said.
“The high comorbidity burden highlighted in this study, in terms of number and severity of type 2 inflammatory conditions, suggests the importance of identifying patients with type 2 inflammation,” researchers said.
“The high comorbidity burden...
04/04/2023
First Report Managed Care
News
04/03/2023
Jolynn Tumolo
Patients with progression independent of relapse activity (PIRA) within 5 years of multiple sclerosis diagnosis had a 26-fold higher risk of developing severe disability compared with patients with PIRA late in the disease.
Patients with progression independent of relapse activity (PIRA) within 5 years of multiple sclerosis diagnosis had a 26-fold higher risk of developing severe disability compared with patients with PIRA late in the disease.
Patients with progression...
04/03/2023
Neurology
News
04/03/2023
Jolynn Tumolo
Women with higher lifetime cumulative estrogen exposure may have a lower risk of stroke overall as well as ischemic stroke and intracerebral hemorrhage subtypes.
Women with higher lifetime cumulative estrogen exposure may have a lower risk of stroke overall as well as ischemic stroke and intracerebral hemorrhage subtypes.
Women with higher lifetime...
04/03/2023
Neurology
News
03/31/2023
Jolynn Tumolo
The risk of major depression in both men and women increases with the number of family members with major depression, study finds.
The risk of major depression in both men and women increases with the number of family members with major depression, study finds.
The risk of major depression in...
03/31/2023
Psych Congress Network
News
03/30/2023
Jolynn Tumolo
The findings suggest patient-reported outcome measures provide valuable information on the well-being of patients with multiple sclerosis, researchers said. 
The findings suggest patient-reported outcome measures provide valuable information on the well-being of patients with multiple sclerosis, researchers said. 
The findings suggest...
03/30/2023
Veterans Health Today
News
03/30/2023
Jolynn Tumolo
A Class II recall has been issued for methylphenidate transdermal system patches due to defective delivery systems.
A Class II recall has been issued for methylphenidate transdermal system patches due to defective delivery systems.
A Class II recall has been...
03/30/2023
Pharmacy Learning Network
News
03/29/2023
Jolynn Tumolo
Low femoral neck and total body bone mineral density (BMD), as well as low trabecular bone score, were associated with an increased risk of dementia in study findings published in Neurology.
Low femoral neck and total body bone mineral density (BMD), as well as low trabecular bone score, were associated with an increased risk of dementia in study findings published in Neurology.
Low femoral neck and total body...
03/29/2023
Neurology
News
03/29/2023
Jolynn Tumolo
Researchers investigated the lifetime cost effectiveness of standard therapy with vs without an SGLT2 inhibitor to reduce the risk of adverse outcomes in patients with heart failure.
Researchers investigated the lifetime cost effectiveness of standard therapy with vs without an SGLT2 inhibitor to reduce the risk of adverse outcomes in patients with heart failure.
Researchers investigated the...
03/29/2023
First Report Managed Care